Tsev / Cov khoom / Peptides / Paub meej
video
Elamipretide hmoov

Elamipretide hmoov

Cov tsos mob: Dawb los tawm cov hmoov dawb
Specification: 98% min
CAS Nr .: 736992-21-5
Cov roj formula: C32H49N9O5
Molecular Luj: 639.79
PIB: 205-858-1
Txee Lub neej: 2 Xyoo Kev Cia Siab
Tshuag: Cov Tshuag Tshiab
Daim ntawv pov thawj: COA, GMP, ISO, HACCP
Kev Pabcuam: OEM & ODM Kev Pabcuam

Khoom Taw qhia

Elamipretide hmoov CAS 736992-21-5|SS-31 Peptide Supplier Tuam Tshoj|GMP Kev Tshawb Fawb Peptide Chaw Tsim Tshuaj

Core Muag Cov Ntsiab Lus

✅ Ntau dua lossis sib npaug li 98% HPLC Purity Research-Grade Peptide Khoom

✅ LC-MS Full Cyclic Octapeptide Sequence & Disulfide Bond Verification

✅ Batch-Specific COA, HPLC & MS Test Reports Muaj

✅ Optimized Fmoc SPPS Cyclization Workflow, In-house Independent QC Laboratory

✅ Cov ntaub ntawv xa tawm thoob ntiaj teb & hla ciam teb Cold-chain Logistics Support

✅ Custom Peptide Purification & Salt-form Adjustment Service

 

Elamipretide Powder yog dab tsi?

 

Elamipretide hmoov, tseem hu ua SS-31 lossis MTP-131, yog cov khoom siv hluavtaws-cationic Szeto-Schiller tetrapeptide uas muaj D-arginine thiab non-canonical 2,6-dimethyl-L-tyrosine (Dmt) residue. Nws selectively accumulates nyob rau hauv puab mitochondrial membrane ywj siab ntawm mitochondrial membrane muaj peev xwm, khi nruj rau cardiolipin, stabilizes cristae architecture, khaws cia electron-transport-chain supercomplex sib dhos thiab suppresses mitochondrial reactive oxygen hom tiam. Kev siv dav dav rau kev mob mitochondrial, ischemia-reperfusion raug mob, tiv thaiv plawv, mob raum thiab kev laus-txog oxidative-kev nyuaj siab ua ntej kev soj ntsuam.

 

Tsim los ntawm optimized Fmoc solid-phase peptide synthesis nrog tshwj xeeb coupling raws tu qauv rau loj Dmt lub tsev thaiv, multi-theem gradient HPLC purification thiab tswj lyophilization txheej txheem, pebElamipretide hmoovminimizes deletion-sequence by-products thiab oxidative degradation impurities, xa cov biochemical ruaj khov thiab zoo ib yam batch-to-batch zoo. HDM BIO ua haujlwm rau lub ntiaj teb biotech labs thiab cov kws tshuaj R & D pab pawg nrog cov khoom siv hauv chav kuaj thiab cov khoom loj loj. Cov khoom siv peptide no nruj me ntsis txwv rau kev tshawb fawb hauv chav kuaj tsuas yog siv thiab tsis tuaj yeem siv ncaj qha rau tib neeg kev tswj hwm kev kho mob.

 

Dab tsi yog Cov Lus Qhia Tshwj Xeeb ntawm Elamipretide Powder?

 

Txhua pawg tsim khoom ntawm Elamipretide raug kuaj dual QC (HPLC + LC-MS) hauv HDM BIO analytical laboratory. Tshwj xeeb batch COA yuav raug xa tawm rau txhua qhov kev txiav txim yuav khoom ntau.

 

Yam khoom

Specification

Kev tshwm sim

Qhov tshwm sim

Dawb rau tawm -dawb hmoov

Zoo ib yam

Purity (HPLC)

Ntau dua lossis sib npaug li 98%

99.58%

MS Identity

Raws li tus qauv siv

Kev lees paub

Xaus

Cosmetic raw khoom xav tau

Dhau

 

Elamipretide vs Lwm Mitochondria-Targeting Peptides

 

Rau cov neeg yuav khoom nrhiav mitochondrial-acting bioactive peptides rau oxidative-stress thiab bioenergetics pharmacology kev tshawb fawb, qhov kev sib piv no qhia meej qhov sib txawv ntawm cov hom phiaj raw khoom:

 

Khoom Target Mechanism Tus yam ntxwv Daim Ntawv Thov Kev Tshawb Fawb Tseem Ceeb CAS Nr
Elamipretide (SS-31) khi inner-mitochondrial-membrane cardiolipin; Stabilizes ua pa supercomplex, txo ROS ntawm qhov chaw, non-membrane-muaj peev xwm-dependent mitochondrial enrichment Tetrapeptide nrog D-Arg thiab tsis yog-natural Dmt hloov residue; aromatic-cationic Szeto-Schiller peptide Ischemia-reperfusion raug mob, kev tiv thaiv plawv-lub raum, Barth syndrome, mitochondrial myopathy, aging-related bioenergetic poob kev tshawb fawb 736992‑21‑5
Tib neeg Mitochondrial-derived peptide; anti-apoptotic ntawm cell-surface receptor & intracellular Bax inhibition, modulates insulin rhiab heev 24-mer endogenous-origin peptide uas muaj Met & dawb Cys residue Neurodegeneration, cellular senescence, metabolic teeb meem soj ntsuam 330936‑69‑1
MOTS-c Mitochondrial-encoded luv peptide; activates AMPK signaling, tswj cov piam thaj homeostasis 16-amino-acid mitochondrial-derived peptide Kev xyaum ua-mimetic kev tshawb fawb, insulin-tiv taus, kev tshawb fawb skeletal-muscle metabolic 162117‑66‑4

 

Tshooj lus no suav nrog cov lus tseem ceeb ntev: elamipretide SS-31 peptide, elamipretide vs humanin, cardiolipin khi peptide raw khoom.

 

Yuav Ua Li Cas Yuav Elamipretide Powder los ntawm Lub Chaw Muag Khoom Zoo?

 

Thaum muab khoomElamipretide hmoovrau mitochondrial bioenergetics, ischemia-reperfusion thiab mitochondrial-kab mob ua ntej kev tshawb fawb, R & D pab pawg thiab cov neeg siv khoom thoob ntiaj teb peptide yuav tsum ntsuas tsib yam tseem ceeb kom tsis txhob muaj kev pheej hmoo ntawm kev ua tau zoo thiab khoom noj khoom haus:

  • HPLC purity validation: Paub meej ntau dua los yog sib npaug rau 98% purity nrog rau ua tiav impurity chromatogram, ua tib zoo mloog rau deletion-sequence impurities originated los ntawm low-reactivity Dmt residue coupling
  • LC-MS kev pom zoo: Txheeb xyuas qhov ntev-ntev tetrapeptide suav nrog D-arginine thiab 2,6-dimethyl-tyrosine hloov kho tus kheej
  • Batch-specific documentation: Guarantee txhua qhov kev txiav txim tuaj yeem sib phim nrog COA cov ntaub ntawv ywj pheej
  • Mature synthesis muaj peev xwm: Xaiv cov neeg muag khoom nrog cov kev paub dhau los ua cov peptides siv cov khoom kim heev, tsis muaj-canonical amino-acid tsev blocks
  • Kev pabcuam xa tawm thoob ntiaj teb: Txheeb xyuas cov neeg muag khoom tuaj yeem muab cov ntaub ntawv txhawb nqa tag nrho rau kev lis kev cai thoob ntiaj teb

HDM BIO muab kev tshawb fawb-qib Elamipretide nrog tag nrho cov ntaub ntawv zoo, hloov tau yam tsawg kawg nkaus txiav txim kom muaj nuj nqis thiab thoob ntiaj teb kev xa khoom rau cov khoom siv me me thiab kev yuav khoom mus sij hawm ntev.

 

Elamipretide Powder Nqe & Daim Ntawv Qhia Ntau Yam 2026

 

Cov neeg yuav khoom nrhiav Elamipretide hmoov nqe, tej peptide hais thiab cov nqe lus xa tuaj yeem xa mus rau cov ntaub ntawv tseem ceeb hauv qab no:

  • Yam tsawg kawg nkaus Order Quantity: Flexible MOQ, milligram & gram-theem sim kuaj muaj; kilogram bulk mov rau kev tshawb fawb txuas ntxiv
  • Qauv Nqi: Cov qauv sim rau kev soj ntsuam hauv chav kuaj; hu rau pab neeg muag khoom kom tau txais cov qauv hais
  • Bulk Kilogram Quotation: Tiered pricing txoj cai, kev txiav txim loj loj txaus siab rau cov nqi sib tw
  • Lub Sijhawm Lead Lub Sijhawm: Tus qauv coj lub sijhawm nyob ntawm qhov kev txiav txim ntim; tshwj xeeb lead-lub sij hawm siv vim kev cai non-canonical amino-acid raw-material npaj; kev muag khoom yuav lees paub lub sijhawm tsim khoom raws sijhawm raws li kev nug
  • Shipping Options: Kev thauj mus los txias-chain pom zoo; zam lub sijhawm ntev ntawm chav tsev kub; peb muab cov ntawv xa nyiaj ua lag luam, cov ntawv ntim khoom thiab MSDS rau kev lis kev cai thoob ntiaj teb

Ntau yam tseem ceeb cuam tshuam rau qhov kawg hais: qib purity, customized kuaj yuav tsum tau, tshwj xeeb ntim specifications thiab txias-chain logistics nqi. Hu rau peb pab neeg muag khoom kom paub cov lus hais tawm tshiab.

 

Elamipretide Powder Procurement Guide for Global Buyers

 

Ua ntej kos npe rau daim ntawv cog lus kev yuav khoom rau kev hloov pauv-amino-acid-muaj cov khoom siv tshwj xeeb peptide raw khoom, pab pawg neeg yuav khoom thoob ntiaj teb yuav tsum ua tiav cov kauj ruam pov thawj no txhawm rau txo cov kev pheej hmoo:

  1. Kev pov thawj ntawm tus neeg muag khoom: Paub meej tias tus neeg muag khoom muaj kev ywj pheej peptide synthesis Rhiav thiab hauv tsev QC kuaj nrog kev ua haujlwm ntawm Szeto-Schiller-chav hloov kho-peptide ntau lawm
  2. Kev tshuaj xyuas cov ntaub ntawv: Thov ua ntej xa khoom xa tuaj batch COA, HPLC chromatogram thiab LC-MS daim ntawv qhia txog tus kheej; paub meej tias hloov kho-qhov seem seem-kos npe match
  3. Kev pom zoo ntawm cov khoom: Txheeb xyuas peptide purity tus qauv, impurity profile thiab nruj txias-cia specifications phim koj cov kev sim tsim; Aqueous reconstituted kua yog lub teeb- thiab oxidation-sensitive
  4. MOQ & lub sij hawm ua: Paub meej tias muaj Tshuag, tshwj xeeb raw-khoom siv lead-time thiab kev txiav txim hloov txoj cai
  5. Shipping cov ntaub ntawv: Paub meej tias tus neeg muag khoom tuaj yeem muab tag nrho cov ntaub ntawv xav tau rau kev xa tawm kev lis kev cai hauv koj cheeb tsam

 

Hais txog HDM BIO Elamipretide Manufacturing Capability

 

HDM BIO muaj ntau tshaj 10 xyoo ntawm kev paub tsom mus rau Fmoc solid-phase peptide synthesis thiab complex tshwj xeeb peptide raw khoom tsim uas muaj xws li D-configuration amino-acids thiab non-canonical hloov tyrosine tsev blocks.

  • Dedicated SPPS cov kab ntau lawm nruab rau txuas ntxiv-lub sij hawm coupling raws tu qauv xav tau los ntawm sterically-hindered bulky 2,6-dimethyl-L-tyrosine residue
  • Lub chaw soj ntsuam ywj pheej nruab nrog HPLC, LC-MS, ntsuas dej noo thiab cov cuab yeej ntsuas hnyav-hlau; tshwj xeeb pawg-spectrometry workflow rau hloov kho-residue peptide tus kheej validation
  • Peptide cov khoom xa tawm mus rau ntau dua 70 lub teb chaws, ua haujlwm hauv tsev kawm ntawv labs, biotech startups thiab kws tshuaj R & D lub koom haum
  • Muaj peev xwm tsim tau txhua xyoo ruaj khov rau kev tshawb fawb-qib peptide raw cov ntaub ntawv, txhawb kev koom tes ua haujlwm ntev
  • Pab pawg kws tshaj lij nrog kev paub nplua nuj nyob rau hauv Szeto-Schiller peptide series synthesis, impurity tswj thiab kev cai analog hloov kho

Peb lub chaw tsim khoom peptide ua haujlwm tshwj xeeb Fmoc SPPS cov kab ntau lawm nrog hauv tsev HPLC purification thiab LC-MS analytical peev xwm.

 

Dab tsi kev sib tw muaj nyob rau hauv Elamipretide Synthesis & Production?

 

Elamipretide tetrapeptide suav nrog D-arginine thiab sterically bulky non-natural 2,6-dimethyl-L-tyrosine (Dmt). Tsawg coupling efficiency ntawm Dmt lub tsev-thaiv thiab kim-sourced hloov kho amino-acid sawv cev rau core technical bottlenecks cais cov tsim nyog peptide manufacturers los ntawm cov khoom qib qis.

Cov teeb meem tseem ceeb ntawm kev tsim khoom muaj xws li:

  • Bulky 2,6-dimethyl-tyrosine nthuav tawm qhov hnyav steric hindrance thaum sib txuas, yooj yim tsim ib leeg-amino-acid deletion impurities
  • D-Arg epimerization txaus ntshai nyob rau hauv qee qhov kev sib txuas thiab kev sib cais, yuav tsum tau tswj xyuas nruj heev.
  • Tsis yog-canonical Dmt lub tsev-thaiv tsis yog cov khoom lag luam hauv khw, tso siab rau kev npaj cov khoom siv raw, cuam tshuam rau tag nrho cov khoom lag luam.
  • Dmt aromatic nplhaib yog raug rau oxidative degradation thaum lub sij hawm purification thiab lyophilization, uas yuav tshem tawm cardiolipin-binding bioactivity txawm thaum loj tseem tsis hloov.
  • Nyuaj chromatographic sib cais ntawm lub hom phiaj peptide thiab cov qauv zoo sib xws deletion-sequence analogs, yuav tsum tau npaj ntau kauj ruam-HPLC workflow

HDM BIO tau txais cov txheej txheem txuas ntxiv-lub sij hawm ua kom zoo-optimized coupling txheej txheem, epimerization-suppressing base system, multi-theem gradient HPLC purification thiab tag nrho-txheej txheem LC-MS xyuas rau txhua batch. Qhov no txo ​​qis kev tshem tawm-ib ntus, epimer thiab oxidative-degradation impurities thiab lav zoo Elamipretide tetrapeptide qauv thiab ruaj khov batch-rau-batch zoo.

 

Elamipretide Powder ua haujlwm li cas hauv Kev Tshawb Fawb Kev Tshawb Fawb?

 

Raws li tus neeg sawv cev Szeto-Schiller mitochondria-targeted peptide,Elamipretide hmoovnkag mus rau hauv cell membrane thiab concentrates ~ 1000-fold nyob rau hauv lub puab mitochondrial membrane yam tsis xav tau qhov tsis zoo mitochondrial muaj peev xwm ua lub zog tsav. Nws ncaj qha khi cardiolipin, tiv thaiv cardiolipin peroxidation, tswj cristae morphology, stabilizes electron-transport-chain supercomplex los ua ke, curtails electron to thiab txiav mitochondrial ROS tiam ntawm qhov chaw, ntxiv inhibits cytochrome-c tso tawm thiab mitochondrial-driven apoptotic.

 

Nws ua hauj lwm raws li ib tug tseem ceeb kev sim siv compound rau myocardial ischemia-reperfusion raug mob, mob raum mob-kho mob, muaj mob mitochondrial, muaj hnub nyoog-dependent bioenergetic poob thiab mitochondria-targeted tshuaj-kev tshuaj ntsuam xyuas. Tag nrho cov lus piav qhia txog kev siv tsuas yog siv rau hauv-vitro thiab pre-clinical tsiaj tshawb fawb scenarios.

 

Elamipretide Powder Ua li cas ntawm HDM BIO?

 

Elamipretide yuav tsum tau tswj cov txheej txheem nruj rau sterically-hindered hloov-residue coupling, epimerization suppression thiab tiv thaiv oxidation thoob plaws hauv synthesis, cleavage, purification thiab lyophilization.

Nyeem cov lus qhia ntsig txog: Hloov kho Peptide API Manufacturing Guide|Fmoc SPPS Technology piav qhia

 

Ua kom tiav Elamipretide Powder Manufacturing Workflow

Raw Material Inspection (kev cai Dmt & D-Arg tsev-block QC) → Tetrapeptide SPPS Stepwise Coupling (ntev txuas txuas rau qhov loj Dmt residue, epimer-suppressing condition) → Resin Cleavage & Ntiaj teb no Deprotection → Crude Peptide LC Pre-treatment Nqus Lyophilization → Tag Nrho QC Kev Xeem (LC-MS hloov kho-kev txheeb xyuas tus kheej, impurity profileing) → Batch COA Tshaj Tawm → Lub teeb-pov thawj ntim ntim

 

QC Kev Tshawb Fawb Kev Ua Haujlwm

Cov Khoom Raw QC → In-process coupling & epimerization risk monitoring → HPLC Purity Testing → Mass Spectrometry Identity Verification (confirm D-Arg-Dmt uas muaj molecular kos npe) → Moisture & Heavy-Metal Test → Residual Solvent Detection → Approval Batch Release

 

Cov txheej txheem tseem ceeb

Optimized ncua sij hawm coupling workflow daws steric hindrance qhov teeb meem ntawm 2,6-dimethyl-tyrosine residue

Epimer-suppressing reagent system kom tsis txhob D-arginine configuration inversion

Multi-theem high-precision HPLC purification los cais nyuaj-rau-kev paub qhov txawv deletion-sequence peptide impurities

Daim ntawv pov thawj tag nrho LC-MS lees paub qhov tseeb tetrapeptide ib ntus suav nrog cov tsis-canonical Dmt thiab D-Arg residues

Lub teeb-pov thawj kaw lyophilized ntim; lyophilized khoom ruaj khov ntawm -20 degree; aqueous tov yog lub teeb- thiab oxidation-sensitive, pom zoo rau aliquot thiab −80℃cia tom qab reconstitution

 

Dab tsi yog Daim Ntawv Thov Tseem Ceeb ntawm Elamipretide Powder?

 

  1. Kev tshawb fawb tshuaj plawv plawv: Myocardial ischemia-reperfusion raug mob, lub plawv tsis ua hauj lwm mitochondrial bioenergetics, cardiomyocyte oxidative-stress tiv thaiv kev sim
  2. Mitochondrial kab mob ua ntej kev soj ntsuam: Barth Syndrome, mitochondrial myopathy thiab inherited mitochondrial-dysfunction kab mob kev tshawb fawb qauv
  3. Kev tshawb fawb txog kev raug mob hauv lub cev: Lub raum ischemia-reperfusion, khaws cia lub cev thiab tshuaj tiv thaiv oxidative-kev ntxhov siab
  4. Kev tshawb fawb txog kev laus-biology: Hnub nyoog ntsig txog mitochondrial functional poob, senescent-cell mitochondrial kev puas tsuaj mechanism tshawb nrhiav
  5. Kev npaj Biomedical reagent: Cov qauv siv hauv chav kuaj thiab kev sim tswj cov tshuaj reagents rau Szeto-Schiller mitochondria-targeted peptide txoj kev tshawb no
  6. Peptide structure-activity-relationship research: SS-series peptide analog tshuaj ntsuam xyuas thiab cardiolipin-binding qauv optimization

 

Vim li cas thiaj xaiv HDM BIO Raws li koj tus Elamipretide Powder Supplier?

 

  • 10+ xyoo ntawm kev tsim tshwj xeeb peptide kev tsim khoom hauv Suav teb, cov lus txib zoo ntawm peptides uas muaj D-amino-acid thiab non-canonical bulky hloov tyrosine residues
  • Mature extension-coupling SPPS workflow rau sterically-hindered Dmt-muaj Szeto-Schiller peptide, zoo txo ​​qhov deletion-sequence impurities
  • Nruam tag nrho cov qauv pov thawj thiab batch-to-batch impurity-profile tswj rau txhua qhov ntau lawm
  • Ua kom tiav cov ntaub ntawv tshawb xyuas kev tsim khoom rau txhua pawg ntawm Elamipretide
  • Flexible mov: milligram lab kuaj rau kilogram-theem bulk peptide xaj
  • Kev pabcuam xa tawm thoob ntiaj teb npog ntau dua 70 lub tebchaws thiab cheeb tsam
  • Pab neeg tshaj lij kev txhawb nqa mitochondria-targeted peptide kev tshawb fawb & Szeto-Schiller kev cai analog synthesis kev sab laj

 

FAQs Txog Elamipretide Powder

 

Q: Kuv puas tuaj yeem yuav Elamipretide hmoov los ntawm Tuam Tshoj?

A: HDM BIO yog Tuam Tshoj-based tshwj xeeb hloov kho-residue peptide muab kev pabcuam siabElamipretide hmoovrau thoob ntiaj teb kws tshuaj R & D pab pawg thiab biotech laboratories. Peb muab cov qauv tshawb fawb me me thiab kev txiav txim loj loj, txhawb nqa los ntawm cov ntaub ntawv xa tawm ua tiav thiab thoob ntiaj teb kev xa khoom txias.

 

Q: Cov ntaub ntawv dab tsi uas tus neeg tsim khoom Elamipretide yuav tsum muab?

A: Cov neeg muag khoom ntseeg siab tuaj yeem muab cov khoom tshwj xeeb COA, HPLC purity chromatogram, LC-MS cov ntaub ntawv pov thawj tus kheej, MSDS thiab cov ntaub ntawv ua tiav cov ntaub ntawv pov thawj.

 

Q: Tus lej CAS ntawm Elamipretide yog dab tsi?

A: Tus lej CAS npe ntawm Elamipretide yog 736992-21-5.

 

Q: Dab tsi purity qib ntawm Elamipretide hmoov koj tuaj yeem muab tau?

A: Qib kev tshawb fawb qib siab dua lossis sib npaug li 98% HPLC purity. Ntau dua purity specifications thiab Szeto-Schiller series kev cai analog tuaj yeem ua ke rau kev sim tshwj xeeb.

 

Q: Yuav ua li cas lyophilized Elamipretide hmoov yuav khaws cia?

A: Khaws kaw ntawm -20 degree, tiv thaiv lub teeb thiab noo noo. Tsis txhob rov qab khov-thaw cycles. Reconstituted aqueous tov yog susceptible rau lub teeb-triggered oxidation; npaj ib leeg-siv aliquots thiab khaws cia ntawm −80 degree, tsis txhob cia lub sij hawm ntev ntawm 2-8 degree.

 

Q: Kuv puas tuaj yeem tau txais cov qauv Elamipretide ua ntej kev koom tes ntau?

A: Yog. Peb muab milligram rau gram-theem sim cov qauv txuas nrog ua tiav COA thiab cov ntaub ntawv xeem rau kev soj ntsuam kuaj.

 

Q: MOQ rau bulk Elamipretide hmoov yog dab tsi?

A: MOQ yog hloov tau raws li qib purity thiab ntim khoom. Peb txhawb nqa cov kev tshawb fawb me me thiab cov xaj loj loj kom ua tau raws li qhov xav tau sib txawv.

 

Q: Dab tsi yog qhov amino-acid sequence ntawm Elamipretide?

A: D-Arg-2,6-dimethyl-Tyr-Lys-Phe-NH₂ (D-Arg-Dmt-Lys-Phe-NH₂)

 

Kev Tshawb Fawb Txog Kev Tshawb Fawb

 

Kev tshuaj xyuas los ntawm: HDM BIO Peptide Technical Team Expertise: Peptide synthesis D-amino-acid & non-canonical modified-residue specialty peptide manufacturing Analytical chemistry & HPLC/LC-MS modified-peptide kev kuaj tus kheej

Kho tshiab kawg: Lub Yim Hli 2026

Kev lees paub: Tag nrho cov ntsiab lus ntawm cov khoom lag luam yog muab rau kev tshawb fawb kev kawm thiab cov khoom siv raw khoom siv xwb. Tsis yog siv rau tib neeg kev kho mob, kev kuaj mob lossis kev kho mob.

 

Hoobkas

elamipretide-peptide-cleanroom-production-workshop-hdmbio.jpg

elamipretide-solid-phase-peptide-synthesis-equipment-hdmbio.jpg

elamipretide-hplc-lab-quality-control-testing-hdmbio.jpg

Daim ntawv pov thawj

elamipretide-coa-certificate-of-analysis-hdmbio.jpg elamipretide-gmp-manufacturer-qualification-hdmbio.jpg

Shipping & Packing

elamipretide-powder-aluminum-foil-packaging-shipping-hdmbio.jpg

Yuav Thov Li Cas Elamipretide COA, Samples & Bulk Quotation?

 

Peb muab kev pabcuam ib-nres tag nrho-kev pabcuam rau thoob ntiaj teb kev yuav khoom thiab biopharmaceutical R & D cov haujlwm:

 

  • Batch - tshwj xeeb COA
  • MSDS Safety Data Sheet
  • Cov ntaub ntawv pov thawj GMP & ISO
  • Custom Bulk Lag luam wholesale Nqe
  • Cov qauv dawb muaj
  • Dedicated Technical Formulation Support

 

Thov COA Tau Txais Tus Nqi Them Nqi Thov Tus Qauv

 

WhatsApp: +86 19991242181

Email:sales@hdmbio.com

Cim npe nrov: Tuam Tshoj elamipretide hmoov manufacturers, lwm tus neeg, Hoobkas

Xa kev nug

whatsapp

Xov tooj

Tug

Kev nug

hnab